denintuzumab mafodotin inn development codes humanized monoclonal antibodydrug conjugate designed treatment acute lymphoblastic leukemia bcell nonhodgkin consists mab linked monomethyl auristatin f mmaf cytotoxic drug developed seattle genetics denintuzumab refers antibody mafodotin refers mmaf chemical drug phase clinical preliminary phase results bcell malignancies including diffuse large bcell lymphoma dlbcl blineage acute lymphocytic leukemia ball presented ash medical conference dec separate randomized phase trial started evaluate combination rice chemotherapy secondline phase clinical trial frontline dlbcl started trials terminated sponsor based portfolio monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikidenintuzumabmafodotin